Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 809

3.

NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.

Feuerhake F, Kutok JL, Monti S, Chen W, LaCasce AS, Cattoretti G, Kurtin P, Pinkus GS, de Leval L, Harris NL, Savage KJ, Neuberg D, Habermann TM, Dalla-Favera R, Golub TR, Aster JC, Shipp MA.

Blood. 2005 Aug 15;106(4):1392-9. Epub 2005 May 3.

4.

Cellular FLICE/caspase-8-inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma.

Okano H, Shiraki K, Inoue H, Kawakita T, Yamanaka T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Fujikawa K, Murata K, Nakano T.

Lab Invest. 2003 Jul;83(7):1033-43.

PMID:
12861043
5.

NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.

Todaro M, Zerilli M, Triolo G, Iovino F, Patti M, Accardo-Palumbo A, di Gaudio F, Turco MC, Petrella A, de Maria R, Stassi G.

Arthritis Rheum. 2005 Jul;52(7):2179-91.

6.
7.

Fas Ag-FasL coupling leads to ERK1/2-mediated proliferation of gastric mucosal cells.

Li H, Cai X, Fan X, Moquin B, Stoicov C, Houghton J.

Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G263-75. Epub 2007 Nov 8.

PMID:
17991709
8.

Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts.

Tung TC, Oshima K, Cui G, Laks H, Sen L.

Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H964-73.

PMID:
12915385
9.

FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.

Wieckowski E, Atarashi Y, Stanson J, Sato TA, Whiteside TL.

J Cell Biochem. 2007 Jan 1;100(1):16-28.

PMID:
16888780
10.

Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.

Huerta S, Heinzerling JH, Anguiano-Hernandez YM, Huerta-Yepez S, Lin J, Chen D, Bonavida B, Livingston EH.

J Surg Res. 2007 Sep;142(1):184-94. Epub 2007 Jul 2.

PMID:
17603079
11.

Identification and characterization of DEDD2, a death effector domain-containing protein.

Roth W, Stenner-Liewen F, Pawlowski K, Godzik A, Reed JC.

J Biol Chem. 2002 Mar 1;277(9):7501-8. Epub 2001 Dec 11.

12.

c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis.

Owyang AM, Tumang JR, Schram BR, Hsia CY, Behrens TW, Rothstein TL, Liou HC.

J Immunol. 2001 Nov 1;167(9):4948-56.

13.
14.

Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells.

Lajmanovich A, Irisarri M, Molens JP, Pasquier MA, Sotto JJ, Bensa JC, Leroux D, Plumas J.

Br J Haematol. 2004 Mar;124(6):746-53.

PMID:
15009062
15.

Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis.

Stel AJ, Ten Cate B, Jacobs S, Kok JW, Spierings DC, Dondorff M, Helfrich W, Kluin-Nelemans HC, de Leij LF, Withoff S, Kroesen BJ.

J Immunol. 2007 Feb 15;178(4):2287-95.

17.

Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.

Chaganti SR, Chen W, Parsa N, Offit K, Louie DC, Dalla-Favera R, Chaganti RS.

Genes Chromosomes Cancer. 1998 Dec;23(4):323-7.

PMID:
9824205
18.

Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.

Mitsiades CS, Poulaki V, Fanourakis G, Sozopoulos E, McMillin D, Wen Z, Voutsinas G, Tseleni-Balafouta S, Mitsiades N.

Clin Cancer Res. 2006 Jun 15;12(12):3705-12.

20.

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.

Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.

Oncogene. 2006 Dec 7;25(58):7618-34. Epub 2006 Sep 18. Erratum in: Oncogene. 2007 Feb 22;26(8):1256.

PMID:
16983347

Supplemental Content

Support Center